BioCurex, Inc. (BOCX) Files Provisional Patent Application
BioCurex, Inc. is actively involved with product development in cancer diagnostics, imagery, and therapeutic technologies. One of the company's prime areas of focus is its patented RECAF™ technology, which is capable of identifying the RECAF cancer marker in test subjects. The application filed by BioCurex on Tuesday includes the protection of various methods for detecting RECAF in bodily fluids. It goes on to illustrate believed advancements in the area of cancer imaging and treatment based on RECAF technology. "This new patent application is the result of several years of intense work and it reflects the value added to our company…